Contact our breast care nurses 0808 800 6000

Bisphosphonates for primary breast cancer

Bisphosphonates can reduce the risk of primary breast cancer spreading to the bones. Understand what they are, how they work, and the side effects.

1. What are bisphosphonates?

Bisphosphonates are drugs that are used for a number of reasons.

For treating primary breast cancer

For , bisphosphonates may be used to reduce the risk of breast cancer spreading to the bones and other parts of the body.

Zoledronic acid, which you may hear called by the brand name Zometa, is the bisphosphonate most commonly used in primary breast cancer.

Other uses of bisphosphonates

In addition to being used in primary breast cancer, zoledronic acid and other types of bisphosphonates may also be prescribed:

2. How bisphosphonates work

Bisphosphonates slow down or prevent loss of bone tissue. You may hear these drugs called bone-strengthening treatment.

In all our bodies, whether or not we have cancer, bone tissue breaks down over time and is replaced with new bone tissue. This is a natural process called bone remodelling.

Cancer cells seem to be drawn to areas where bone remodelling is taking place, so secondary breast cancer commonly affects the bones (as well as the lungs, liver and brain).

Bisphosphonates work by being absorbed in areas of the body where there is a lot of bone remodelling. This interferes with the remodelling process, so may reduce the risk of breast cancer spreading to the bones and elsewhere in the body.

3. When are bisphosphonates prescribed?

Bisphosphonates are prescribed for women who have been through the menopause (post-menopausal women). They can be given regardless of whether the menopause has occurred naturally or because of breast cancer treatment.

The benefits of using these drugs before the menopause are less clear.

Bisphosphonates are usually prescribed for women who have had treatment for invasive breast cancer that has spread to the under the arm.

They may also be prescribed when women don’t have cancer in their lymph nodes but other factors increase the risk of cancer returning.

Bisphosphonates for primary breast cancer are usually started within 3 months of final surgery.

If you are having after surgery, you will usually start taking a bisphosphonate within 2 months of completing chemotherapy.

 

4. How are bisphosphonates given?

The bisphosphonate you’re given depends on what your treatment team suggest and what your preferences are.

The treatment will continue for around 2 to 3 years.

Zoledronic acid is given as a drip into a vein in your hand or arm (intravenously). It can be given every 6 months for 3 years or every 3 months for 2 years.

5. Side effects of bisphosphonates

Like all drugs bisphosphonates have some side effects. Your treatment team will explain them to you. 

Was this helpful?

Was this helpful?
Please tell us what you liked about it.
Please tell us why.
We’re sorry you didn’t find this helpful.
Please do not include personal details and be aware we cannot respond to comments.

Quality assurance

This information was published in November 2023. We will revise it in November 2025.

  • support-cta-icon-telephone

    Call our free helpline

    If you have any concerns about breast cancer, or just want to talk, our specialist nurses are here for you.

    Lines open: Monday to Friday - 9am to 4pm; Saturday - 9am to 1pm

  • support-cta-icon-email

    Explore ways to talk to our nurses

    It can be difficult to talk to someone in person about breast cancer concerns. Explore other ways you can ask a question.

2937.challengers wall 10.jpg
Support service

Someone Like Me

You never have to face breast cancer alone. Find somebody who understands what you're going through with Someone Like Me.

Share this page